News

Stocktwits on MSN7h
Why Nano-Cap Adagio Medical Saw The Highest Weekly Spurt In Retail Following Among Healthcare Stocks
Shares of Adagio Medical Holdings, Inc. (ADGM) experienced a significant surge in retail investor interest last week as they ...
MassDevice2d
Imricor kicks off first-in-human ventricular ablation trial
Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.
FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT
EBR Systems, Inc. (ASX: EBR) has received FDA approval of the WiSE® System, which marks a significant leap forward in the treatment of heart failure. Unlike conventional CRT, the WiSE System is the ...
Adagio Medical receives FDA Breakthrough Device designation for vCLAS system
Adagio Medical (ADGM) announced it received Breakthrough Device designation from the FDA for its vCLAS Cryoablation System. The designation is ...
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...
Imricor wins European assent for its world-leading heart tool
Special Report: Imricor Medical Systems has secured CE Mark certification for its Advantage-MR system under the European ...
MassDevice5d
EBR wins FDA nod for leadless pacing system
EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...
Physician's Weekly6d
Right Ventricular Function Predicts Outcomes After PMVR
The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...